Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 421Generated: October 27, 2026

2-(4-bromophenyl)-N,N-dimethylacetamide → HCID 118717961, compound

https://huagongshe.com/reaction/421

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-(4-bromophenyl)-N,N-dimethylacetamideHCID 4631595—
ReactantHCID 178418219HCID 178418219—
ReagentCesium carbonateHCID 10796—
Catalyst2-(Dicyclohexylphosphino)biphenylHCID 2734216—
CatalystPalladium (II) acetateHCID 4144353—
Solvent1,4-DioxaneHCID 31275—
ProductHCID 118717961HCID 11871796132.03%

Reaction Conditions

Temperature120 °C

Reaction Steps

8-(4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-amine (94 mg, 0.40 mmol), 2-(4-bromophenyl)-N,N-dimethylacetamide (103 mg, 0.40 mmol), Cesium carbonate (198 mg, 0.61 mmol), Palladium(II) acetate (9.09 mg, 0.04 mmol) and 2-(Dicyclohexylphosphino)biphenyl (14.18 mg, 0.04 mmol) were added to a 0.5-2 mL microwave vial. The vial was capped and flushed with nitrogen. dioxane (3 mL) was added and the vial was flushed with additional nitrogen before it was heated by microwave irradiation at 120°C for 1.5h. The reaction mixture was cooled to r.t. and water and EtOAc were added and the layers were separated. The aqueous phase was extracted with EtOAc (3x). The combined organic phases were washed with brine, dried (phase separator) and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography using a gradient of 0-3% MeOH in EtOAc over 12 min. The desired fractions were combined to result in 2-(4-(8-(4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-ylamino)phenyl)-N,N-dimethylacetamide (51.0 mg, 32.0 %)

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-31e2f0a986f6432689bfa64e01da3c0f
Source note750 AstraZeneca ELN dataset